GAMBA, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.942
EU - Europa 1.516
AS - Asia 1.073
AF - Africa 10
SA - Sud America 6
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.554
Nazione #
US - Stati Uniti d'America 1.926
CN - Cina 1.041
IE - Irlanda 439
UA - Ucraina 313
FI - Finlandia 221
DE - Germania 159
IT - Italia 113
SE - Svezia 113
GB - Regno Unito 78
FR - Francia 26
BE - Belgio 15
PL - Polonia 15
CA - Canada 13
IR - Iran 11
IN - India 8
MU - Mauritius 8
RU - Federazione Russa 5
AU - Australia 4
BR - Brasile 4
NL - Olanda 4
SG - Singapore 4
CZ - Repubblica Ceca 3
MX - Messico 3
AT - Austria 2
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
EU - Europa 2
GR - Grecia 2
ID - Indonesia 2
RO - Romania 2
TH - Thailandia 2
TR - Turchia 2
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SM - San Marino 1
Totale 4.554
Città #
Dublin 437
Chandler 431
Jacksonville 404
Nanjing 321
Ashburn 120
Nanchang 117
Shenyang 91
Lawrence 89
Princeton 89
Hebei 86
Wilmington 85
Changsha 84
Jiaxing 75
Beijing 68
Medford 61
Ann Arbor 59
Boardman 56
Tianjin 55
Helsinki 50
Hangzhou 46
Woodbridge 34
Milan 23
Des Moines 20
Verona 17
Brussels 15
Radomsko 14
Shanghai 14
Jinan 13
Kunming 13
Seattle 12
Norwalk 11
Toronto 11
Taizhou 10
Fairfield 9
Houston 9
Leawood 9
San Francisco 9
Los Angeles 8
Ningbo 8
Dearborn 7
New York 7
Auburn Hills 6
Fuzhou 6
Falls Church 5
Guangzhou 5
Zanjan 5
Zhengzhou 5
Chicago 4
Pavia 4
Rome 4
Washington 4
Ardabil 3
Ceska 3
Lanzhou 3
Monmouth Junction 3
Pune 3
Sydney 3
Zapopan 3
Bangkok 2
Barcelona 2
Bari 2
Bologna 2
Borås 2
Cairo 2
Caserta 2
Florence 2
Genova 2
Las Vegas 2
Lecco 2
London 2
Mumbai 2
Napoli 2
Orange 2
Piscataway 2
Poggibonsi 2
Pontedassio 2
Sacramento 2
Shaoxing 2
São Paulo 2
Tappahannock 2
Vienna 2
Alexandria 1
Almere Stad 1
Andover 1
Athens 1
Auckland 1
Belfast 1
Bellinzona 1
Berlin 1
Carcare 1
Changchun 1
Cork 1
Dhaka 1
Gravedona 1
Henderson 1
Huizen 1
Jeddah 1
Kingston 1
Latina 1
Lima 1
Totale 3.231
Nome #
Screening dei difetti dell'emostasi con Platelet Function Analyzer (PFA-100) in donne con meno-metrorragia 112
L'artropatia e l'emartro ricorrente nelle coagulopatie congenite: l'influenza del trattamento. 86
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. 82
Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome 81
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 80
Caratteristiche dell'emartro ed evoluzione in artropatia nelle coagulopatie congenite: osservazione su 145 casi afferenti al centro emofilia di Pavia 78
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 77
Atherosclerosis, vascular damage, thrombotic risk factors and congenital bleeding disorders 73
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 72
Acquired von Willebrand syndrome and monoclonal gammopathy: clinical characterization and recovery to infusion of VWF-containing concentrates 68
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 68
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 66
L'artropatia e l'emartro nelle coagulopatie congenite: l'influenza del trattamento 65
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 64
Bleeding disorders in children with reccurent tonsillitis and prolonged aPTT 64
Clotting alterations in primary systemic amyloidosis. 64
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 62
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. 62
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 61
Liver damage and homocysteine plasma levels in haemophilia 60
Vascular damage, prothrombotic risk factor and trombosis in patients with inherited bleeding disorders 60
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 60
Desmopressin and platelets: In vitro and in vivo studies 60
An unconventional case of scurvy. 60
Efficacy and safety of high doses of FEIBA for major surgery in a patient with haemophilia A and high titre inhibitor 59
Patterns of bleeding,comorbidities, and clinical courses in acquired hemophilia A (AHA) and in acquired von Willebrand disease (AVWD): Experience from a single hemophiliaentre in Pavia 59
Platelet-independent defect in hemostasis associated with sirolimus use 59
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 58
Renal diseases in haemophilic patients: pathogenesis and clinical management. 58
Long-term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: what's happened after 30 years of follow up? 58
Malattia di von Willebrand acquisita in 2 pazienti con malattia infiammatoria cronica intestinale 58
In vitro and in vivo effects of desmopressin on platelet function 58
Cardiovascular disease, hyperhomocysteinemia and atherothrombotic risk factors in psoriatic patients 57
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 56
The behaviour of physiologic and acquired anticoagulants in patients with hyperhomocysteinemia and thrombotic complications 56
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 56
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. 55
Treatment of bleeding episodes in acquired haemophilia with activated prothrombin complex concentrate: what is the optimal therapy? 55
Valutazione dell'artropatia in soggetti affetti da emofilia. 55
Homocysteine plasma levels and vascular damage in congenital clotting factor deficiencies 55
Influenza del polimorfismo C677T del gene della MTHFR sui livelli di omocisteina plasmatici e sul rischio trombotico 54
Prevalenza di trombosi arteriose e venose in presenza delle mutazioni G20210A del gene della protrombina e R506Q del gene del FV (Leiden) 54
Performance in sports of children and adolescents with hereditary bleeding disorders 53
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. 53
Thrombotic markers and mitral valve prolapse in migraine with and without aura at childhood onset 52
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 52
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. 52
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 52
Imbalance of oxidant and antioxidant mechanism in ischaemic heart diseases 51
Acquired von Willebrand syndrome in inflammatory bowel disease 51
Mitral valve prolapse and prothrombotic risk factors in children and adolescents with migraine with aura and other idiopathic headaches 50
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 50
Von Willebrand factor/factor VIII behaviour and haemorrhagic manifestations in patients with neurofibromatosis type I 49
La valutazione della qualità della vita e della artropatia nel paziente emofilico adulto. 49
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 48
Prolonged aPTT occasionally detected in children before adenotonsillectomy and bleeding disorders 48
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 47
Haemarthroses and arthropathy in mild/moderate haemophilia: data collected from a single Haemophilia Centre, Pavia, Italy 47
Expression of dipeptidylaminopeptidase IV-CD26 in circulating lymphocytes of homophilic subjects 46
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 46
Castleman's disease with coagulation defect. A case report. 46
Normalization of homocysteine plasma levels improves the physiological anticoagulation in patients with thromboembolic diseases 46
THROMBOPHILIC SCREENING IN TURNER SYNDROME. 45
Platelet function after in vivo and in vitro treatment with thrombolytic agents 45
Clotting alterations in primary systemic amyloidosis 43
Treatment and progression of liver damage in HCV+ haemophiliacs: over 15 years follow up 42
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. 42
Bleeding tendency of unknown origin and protein Z levels. 42
Risk factors of thrombosis in poorly controlled inflammatory bowel diseases: benefecial effect of LMW heparin as adjuvant therapy 40
Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre 39
Modalità di diagnosi e caratteristiche cliniche della M di von Willebrand acquisita 39
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 38
Thromboembolic disease and thrombotic risk factors: The effect of treating Hìhyperhomocysteinemia on physiological anticoagulation 37
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 37
Two years prophylaxis with FEIBA and inhibitors levels in a high responder haemophilic patient 35
HEPARIN INFUSION FACILITATES PLATELETS ACTIVABILITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO HAVE UNDERGONE THROMBOLYTIC THERAPY 35
Ruolo patogenetico delle alterazioni emocoagulative nell'insorgenza di s poliabortiva e di patologie ostetriche 33
Homocysteine, vitamin b12 and folic acid levels in psoriasi patients and correlation with disease severity. 33
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 32
Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis 31
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 31
Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by agnogenic myeloid metaplasia 29
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study 28
Haemostasis and low molecular weight heparin (LMWH) therapy in chronic inflammatory bowel diseases (IBD) not responsive to conventional therapy. 28
Interobserver reliability of ultrasound assessment of haemophilic arthropathy: Radiologist vs. non-radiologist 27
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants 27
Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage. 26
Homocysteine and liver steatosis in HCV infected haemophiliacs 24
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. 24
Totale 4.625
Categoria #
all - tutte 14.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 1 27
2019/20201.241 351 518 7 59 2 68 23 69 4 93 44 3
2020/2021583 74 53 18 60 2 77 5 94 15 90 77 18
2021/2022418 12 0 13 9 3 10 13 20 33 13 50 242
2022/20231.270 146 85 2 111 148 137 0 62 508 17 35 19
2023/2024351 67 51 18 31 48 81 0 34 5 10 6 0
Totale 4.625